founders raise stake
** Biopharma company's shares ACXP.O rise 6.3% to $5.9
after the bell
** Top investors and co-founders Robert DeLuccia and David
Luci raise stakes to 13% and 13.2%, respectively
** Luci held 10.87%, while DeLuccia owned 10.55% as of June
25 - Refinitiv data,
** Stock debuted on the Nasdaq on June 25 and has fallen 25%
from its IPO price
(Reporting by Dania Nadeem in Bengaluru)
((Dania.Nadeem@thomsonreuters.com;))
Recent news on Acurx Pharmaceuticals
See all newsBrief: Acurx Pharmaceuticals Receives FDA Conditional Acceptance
Acurx Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Acurx Pharmaceuticals Q2 loss widens on higher R&D costs
Acurx Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Brief: FDA Provides Further Regulatory Guidance To Acurx Pharmaceuticals For The Ibezapolstat Clinical Development Program